Obesity: impact of infections and response to vaccines

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 35, Issue 3, 2016, Pages 325-331

  Tagliabue, C ^a   Principi, N ^a   Giavoli, C ^a   Esposito, S ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; VACCINE;

HIGH RISK PATIENT; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOREGULATION; INFECTION; OBESITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; ANIMAL; COMMUNICABLE DISEASE; COMPLICATION; HOST PATHOGEN INTERACTION; IMMUNITY; IMMUNOLOGY; IMMUNOMODULATION; METABOLISM;

ANIMALS; COMMUNICABLE DISEASES; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE SYSTEM; IMMUNITY; IMMUNOMODULATION; OBESITY; RISK FACTORS; VACCINES;

EID: 84959466178     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-015-2558-8     Document Type: Review

References (83)

1. World Health Organization (WHO). Global Strategy on Diet, Physical Activity and Health. Childhood overweight and obesity. Available online at: http://www.who.int/dietphysicalactivity/childhood/en/. Accessed 21 Oct 2015
2. Li S, Chen W, Sun D, Fernandez C, Li J, Kelly T et al (2015) Variability and rapid increase in body mass index during childhood are associated with adult obesity. Int J Epidemiol (in press)
3. l’Allemand-Jander D (2010) Clinical diagnosis of metabolic and cardiovascular risks in overweight children: early development of chronic diseases in the obese child. Int J Obes (Lond) 34(Suppl 2):S32–S36
4. World Health Organization (WHO). Noncommunicable diseases and mental health. Global status report on noncommunicable diseases 2014. Available online at: http://www.who.int/nmh/publications/ncd-status-report-2014/en/. Accessed 21 Oct 2015
5. Brown CL, Halvorson EE, Cohen GM, Lazorick S, Skelton JA (2015) Addressing childhood obesity: opportunities for prevention. Pediatr Clin North Am 62:1241–1261
6. Abdullah A, Wolfe R, Stoelwinder JU, de Courten M, Stevenson C, Walls HL et al (2011) The number of years lived with obesity and the risk of all-cause and cause-specific mortality. Int J Epidemiol 40:985–996
7. Pierce AM, Brown LK (2015) Obesity hypoventilation syndrome: current theories of pathogenesis. Curr Opin Pulm Med 21:557–562
8. Lagergren J (2011) Influence of obesity on the risk of esophageal disorders. Nat Rev Gastroenterol Hepatol 8:340–347
9. Al-Zahrani MS, Bissada NF, Borawskit EA (2003) Obesity and periodontal disease in young, middle-aged, and older adults. J Periodontol 74:610–615
10. Cantürk Z, Cantürk NZ, Cetinarslan B, Utkan NZ, Tarkun I (2003) Nosocomial infections and obesity in surgical patients. Obes Res 11:769–775
11. Tucker CE, Lockwood AM, Nguyen NH (2014) Antibiotic dosing in obesity: the search for optimum dosing strategies. Clin Obes 4:287–295
12. Huttunen R, Syrjänen J (2013) Obesity and the risk and outcome of infection. Int J Obes (Lond) 37:333–340
13. Milner JJ, Beck MA (2012) The impact of obesity on the immune response to infection. Proc Nutr Soc 71:298–306
14. Romacho T, Elsen M, Röhrborn D, Eckel J (2014) Adipose tissue and its role in organ crosstalk. Acta Physiol (Oxf) 210:733–753
15. Fasshauer M, Blüher M (2015) Adipokines in health and disease. Trends Pharmacol Sci 36:461–470
16. Grant RW, Dixit VD (2015) Adipose tissue as an immunological organ. Obesity (Silver Spring) 23:512–518
17. Caldefie-Chezet F, Poulin A, Vasson MP (2003) Leptin regulates functional capacities of polymorphonuclear neutrophils. Free Radic Res 37:809–814
18. Montecucco F, Bianchi G, Gnerre P, Bertolotto M, Dallegri F, Ottonello L (2006) Induction of neutrophil chemotaxis by leptin: crucial role for p38 and Src kinases. Ann N Y Acad Sci 1069:463–471
19. Loffreda S, Yang SQ, Lin HZ, Karp CL, Brengman ML, Wang DJ et al (1998) Leptin regulates proinflammatory immune responses. FASEB J 12:57–65
20. Zhao Y, Sun R, You L, Gao C, Tian Z (2003) Expression of leptin receptors and response to leptin stimulation of human natural killer cell lines. Biochem Biophys Res Commun 300:247–252
21. Claycombe K, King LE, Fraker PJ (2008) A role for leptin in sustaining lymphopoiesis and myelopoiesis. Proc Natl Acad Sci U S A 105:2017–2021
22. Mancuso P (2010) Obesity and lung inflammation. J Appl Physiol (1985) 108:722–728
23. Ozata M, Ozdemir IC, Licinio J (1999) Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. J Clin Endocrinol Metab 84:3686–3695
24. Farooqi IS, Matarese G, Lord GM, Keogh JM, Lawrence E, Agwu C et al (2002) Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest 110:1093–1094
25. Viardot A, Grey ST, Mackay F, Chisholm D (2007) Potential antiinflammatory role of insulin via the preferential polarization of effector T cells toward a T helper 2 phenotype. Endocrinology 148:346–353
26. Maciver NJ, Jacobs SR, Wieman HL, Wofford JA, Coloff JL, Rathmell JC (2008) Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival. J Leukoc Biol 84:949–957
27. Stentz FB, Kitabchi AE (2005) Hyperglycemia-induced activation of human T-lymphocytes with de novo emergence of insulin receptors and generation of reactive oxygen species. Biochem Biophys Res Commun 335:491–495
28. Jacobs SR, Herman CE, MacIver NJ, Wofford JA, Wieman HL, Hammen JJ et al (2008) Glucose uptake is limiting in T cell activation and requires CD28-mediated Akt-dependent and independent pathways. J Immunol 180:4476–4486
29. Fezeu L, Julia C, Henegar A, Bitu J, Hu FB, Grobbee DE et al (2011) Obesity is associated with higher risk of intensive care unit admission and death in influenza A (H1N1) patients: a systematic review and meta-analysis. Obes Rev 12:653–659
30. Van Kerkhove MD, Vandemaele KA, Shinde V, Jaramillo-Gutierrez G, Koukounari A, Donnelly CA et al (2011) Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis. PLoS Med 8:e1001053
31. Kwong JC, Campitelli MA, Rosella LC (2011) Obesity and respiratory hospitalizations during influenza seasons in Ontario, Canada: a cohort study. Clin Infect Dis 53:413–421
32. Akiyama N, Segawa T, Ida H, Mezawa H, Noya M, Tamez S et al (2011) Bimodal effects of obesity ratio on disease duration of respiratory syncytial virus infection in children. Allergol Int 60:305–308
33. Jedrychowski W, Maugeri U, Flak E, Mroz E, Bianchi I (1998) Predisposition to acute respiratory infections among overweight preadolescent children: an epidemiologic study in Poland. Public Health 112:189–195
34. Almond MH, Edwards MR, Barclay WS, Johnston SL (2013) Obesity and susceptibility to severe outcomes following respiratory viral infection. Thorax 68:684–686
35. Smith AG, Sheridan PA, Harp JB, Beck MA (2007) Diet-induced obese mice have increased mortality and altered immune responses when infected with influenza virus. J Nutr 137:1236–1243
36. Semins MJ, Shore AD, Makary MA, Weiner J, Matlaga BR (2012) The impact of obesity on urinary tract infection risk. Urology 79:266–269
37. Basu JK, Jeketera CM, Basu D (2010) Obesity and its outcomes among pregnant South African women. Int J Gynaecol Obstet 110:101–104
38. Usha Kiran TS, Hemmadi S, Bethel J, Evans J (2005) Outcome of pregnancy in a woman with an increased body mass index. BJOG 112:768–772
39. Perdichizzi G, Bottari M, Pallio S, Fera MT, Carbone M, Barresi G (1996) Gastric infection by Helicobacter pylori and antral gastritis in hyperglycemic obese and in diabetic subjects. New Microbiol 19:149–154
40. Suvan J, D’Aiuto F, Moles DR, Petrie A, Donos N (2011) Association between overweight/obesity and periodontitis in adults. A systematic review. Obes Rev 12:e381–e404
41. Chaffee BW, Weston SJ (2010) Association between chronic periodontal disease and obesity: a systematic review and meta-analysis. J Periodontol 81:1708–1724
42. Olsen MA, Higham-Kessler J, Yokoe DS, Butler AM, Vostok J, Stevenson KB et al (2009) Developing a risk stratification model for surgical site infection after abdominal hysterectomy. Infect Control Hosp Epidemiol 30:1077–1083
43. Waisbren E, Rosen H, Bader AM, Lipsitz SR, Rogers SO Jr, Eriksson E (2010) Percent body fat and prediction of surgical site infection. J Am Coll Surg 210:381–389
44. Di Leo A, Piffer S, Ricci F, Manzi A, Poggi E, Porretto V et al (2009) Surgical site infections in an Italian surgical ward: a prospective study. Surg Infect (Larchmt) 10:533–538
45. Beldi G, Bisch-Knaden S, Banz V, Mühlemann K, Candinas D (2009) Impact of intraoperative behavior on surgical site infections. Am J Surg 198:157–162
46. Dupuy A, Benchikhi H, Roujeau JC, Bernard P, Vaillant L, Chosidow O et al (1999) Risk factors for erysipelas of the leg (cellulitis): case–control study. BMJ 318:1591–1594
47. Karppelin M, Siljander T, Vuopio-Varkila J, Kere J, Huhtala H, Vuento R et al (2010) Factors predisposing to acute and recurrent bacterial non-necrotizing cellulitis in hospitalized patients: a prospective case–control study. Clin Microbiol Infect 16:729–734
48. Bartholomeeusen S, Vandenbroucke J, Truyers C, Buntinx F (2007) Epidemiology and comorbidity of erysipelas in primary care. Dermatology 215:118–122
49. Torgerson JS, Lindroos AK, Näslund I, Peltonen M (2003) Gallstones, gallbladder disease, and pancreatitis: cross-sectional and 2-year data from the Swedish Obese Subjects (SOS) and SOS reference studies. Am J Gastroenterol 98:1032–1041
50. Edmonds RD, Cuschieri J, Minei JP, Rosengart MR, Maier RV, Harbrecht BG et al (2011) Body adipose content is independently associated with a higher risk of organ failure and nosocomial infection in the nonobese patient postinjury. J Trauma 70:292–298
51. Hsu A, Aronoff DM, Phipps J, Goel D, Mancuso P (2007) Leptin improves pulmonary bacterial clearance and survival in ob/ob mice during pneumococcal pneumonia. Clin Exp Immunol 150:332–339
52. Mancuso P, Huffnagle GB, Olszewski MA, Phipps J, Peters-Golden M (2006) Leptin corrects host defense defects after acute starvation in murine pneumococcal pneumonia. Am J Respir Crit Care Med 173:212–218
53. Bailie MB, Standiford TJ, Laichalk LL, Coffey MJ, Strieter R, Peters-Golden M (1996) Leukotriene-deficient mice manifest enhanced lethality from Klebsiella pneumonia in association with decreased alveolar macrophage phagocytic and bactericidal activities. J Immunol 157:5221–5124
54. Mancuso P, Lewis C, Serezani CH, Goel D, Peters-Golden M (2010) Intrapulmonary administration of leukotriene B4 enhances pulmonary host defense against pneumococcal pneumonia. Infect Immun 78:2264–2271
55. Uji Y, Yamamoto H, Tsuchihashi H, Maeda K, Funahashi T, Shimomura I et al (2009) Adiponectin deficiency is associated with severe polymicrobial sepsis, high inflammatory cytokine levels, and high mortality. Surgery 145:550–557
56. Weber DJ, Rutala WA, Samsa GP, Santimaw JE, Lemon SM (1985) Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine. JAMA 254:3187–3189
57. Weber DJ, Rutala WA, Samsa GP, Bradshaw SE, Lemon SM (1986) Impaired immunogenicity of hepatitis B vaccine in obese persons. N Engl J Med 314:1393
58. Roome AJ, Walsh SJ, Cartter ML, Hadler JL (1993) Hepatitis B vaccine responsiveness in Connecticut public safety personnel. JAMA 270:2931–2934
59. Wood RC, MacDonald KL, White KE, Hedberg CW, Hanson M, Osterholm MT (1993) Risk factors for lack of detectable antibody following hepatitis B vaccination of Minnesota health care workers. JAMA 270:2935–2939
60. Averhoff F, Mahoney F, Coleman P, Schatz G, Hurwitz E, Margolis H (1998) Immunogenicity of hepatitis B vaccines. Implications for persons at occupational risk of hepatitis B virus infection. Am J Prev Med 15:1–8
61. Simó Miñana J, Gaztambide Ganuza M, Fernández Millán P, Peña Fernández M (1996) Hepatitis B vaccine immunoresponsiveness in adolescents: a revaccination proposal after primary vaccination. Vaccine 14:103–106
62. ul-Haq N, Hasnain SS, Umar M, Abbas Z, Valenzuela-Silva C, Lopez-Saura P (2003) Immunogenicity of 10 and 20 microgram hepatitis B vaccine in a two-dose schedule. Vaccine 21:3179–3185
63. Chow KM, Law MC, Leung CB, Szeto CC, Li PK (2006) Antibody response to hepatitis B vaccine in end-stage renal disease patients. Nephron Clin Pract 103:c89–c93
64. Young KM, Gray CM, Bekker LG (2013) Is obesity a risk factor for vaccine non-responsiveness? PLoS One 8:e82779
65. Estévez ZC, Betancourt AA, Muzio González V, Baile NF, Silva CV, Bernal FH et al (2007) Immunogenicity and safety assessment of the Cuban recombinant hepatitis B vaccine in healthy adults. Biologicals 35:115–122
66. Van der Wielen M, Van Damme P, Chlibek R, Smetana J, von Sonnenburg F (2006) Hepatitis A/B vaccination of adults over 40 years old: comparison of three vaccine regimens and effect of influencing factors. Vaccine 24:5509–5515
67. Reuman PD, Kubilis P, Hurni W, Brown L, Nalin D (1997) The effect of age and weight on the response to formalin inactivated, alum-adjuvanted hepatitis A vaccine in healthy adults. Vaccine 15:1157–1161
68. Lim J, Song YJ, Park WS, Sohn H, Lee MS, Shin DH et al (2014) The immunogenicity of a single dose of hepatitis A virus vaccines (Havrix® and Epaxal®) in Korean young adults. Yonsei Med J 55:126–131
69. Harper SA, Fukuda K, Uyeki TM, Cox NJ, Bridges CB; Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention (CDC) (2005) Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 54(RR-8):1–40
70. Kim YH, Kim JK, Kim DJ, Nam JH, Shim SM, Choi YK et al (2012) Diet-induced obesity dramatically reduces the efficacy of a 2009 pandemic H1N1 vaccine in a mouse model. J Infect Dis 205:244–251
71. Yang WH, Dionne M, Kyle M, Aggarwal N, Li P, Madariaga M et al (2013) Long-term immunogenicity of an AS03-adjuvanted influenza A(H1N1)pdm09 vaccine in young and elderly adults: an observer-blind, randomized trial. Vaccine 31:4389–4397
72. Callahan ST, Wolff M, Hill HR, Edwards KM; NIAID Vaccine and Treatment Evaluation Unit (VTEU) Pandemic H1N1 Vaccine Study Group (2014) Impact of body mass index on immunogenicity of pandemic H1N1 vaccine in children and adults. J Infect Dis 210:1270–1274
73. Talbot HK, Coleman LA, Crimin K, Zhu Y, Rock MT, Meece J et al (2012) Association between obesity and vulnerability and serologic response to influenza vaccination in older adults. Vaccine 30:3937–3943
74. Sheridan PA, Paich HA, Handy J, Karlsson EA, Hudgens MG, Sammon AB et al (2012) Obesity is associated with impaired immune response to influenza vaccination in humans. Int J Obes (Lond) 36:1072–1077
75. Esposito S, Giavoli C, Trombetta C, Bianchini S, Montinaro V, Spada A (2015) Immunogenicity, safety and tolerability of inactivated trivalent influenza vaccine in overweight and obese children. Vaccine (in press)
76. Paich HA, Sheridan PA, Handy J, Karlsson EA, Schultz-Cherry S, Hudgens MG et al (2013) Overweight and obese adult humans have a defective cellular immune response to pandemic H1N1 influenza A virus. Obesity (Silver Spring) 21:2377–2386
77. Russell JH, Ley TJ (2002) Lymphocyte-mediated cytotoxicity. Ann Rev Immunol 20:323–370
78. Teijaro JR, Verhoeven D, Page CA, Turner D, Farber DL (2010) Memory CD4 T cells direct protective responses to influenza virus in the lungs through helper-independent mechanisms. J Virol 84:9217–9226
79. Banga N, Guss P, Banga A, Rosenman KD (2014) Incidence and variables associated with inadequate antibody titers after pre-exposure rabies vaccination among veterinary medical students. Vaccine 32:979–983
80. Berndtsson LT, Nyman AK, Rivera E, Klingeborn B (2011) Factors associated with the success of rabies vaccination of dogs in Sweden. Acta Vet Scand 53:22
81. Eliakim A, Schwindt C, Zaldivar F, Casali P, Cooper DM (2006) Reduced tetanus antibody titers in overweight children. Autoimmunity 39:137–141
82. Ovsyannikova IG, White SJ, Larrabee BR, Grill DE, Jacobson RM, Poland GA (2014) Leptin and leptin-related gene polymorphisms, obesity, and influenza A/H1N1 vaccine-induced immune responses in older individuals. Vaccine 32:881–887
83. Shu CJ, Benoist C, Mathis D (2012) The immune system’s involvement in obesity-driven type 2 diabetes. Semin Immunol 24:436–442